eNauka - pregled
Pregled prema Autor Schadendorf, Dirk
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2024 | Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial![]() | Schadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijusković, Željko P. | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2022 | Efficacy and safety of sequencing with vemurafenib (V) plus cobimetinib (C) followed by atezolizumab (Atezo) in patients (pts) with advanced BRAF(V600)-positive melanoma: Interim analysis of the ImmunoCobiVem study.![]() | Schadendorf, Dirk; ...; Kandolf-Sekulovic, Lidija O; ...; Mijuskovic, Željko P | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2024 | Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study | Asher, Nethanel; Mohr, Peter; Ellebaek, Eva; Bender, Marc; Mangana, Joanna; Kandolf, Lidija O; Gavrilova, Iva; Ascierto, Paolo Antonio; Gogas, Helen; Rutkowski, Piotr;
Schadendorf, Dirk; Bastholt, Lars; Weichenthal, Michael;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
